Skip to main content

Closed

RGNX: REGENXBIO Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-292.3%

ROIC-92.1%

Financially safe

Stretched

Debt / equity3.37×

Interest coverage-5.7×

Current ratio2.62×

REGENXBIO Inc.

RGNXNASDAQ Global Select·USD·Closed

REGENXBIO Inc.

RGNXNASDAQ·USD·Closed

$9.69

−4.25%

$9.69

−$0.43 (4.25%)

52W Range

39thpctl

Volume

0.51×avg

Mkt Cap

500.95MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

39thpctl

Volume

0.51×avg

Market Cap

500.95MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings